|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2007-9-10
|
|
pubmed:abstractText |
Percutaneous coronary intervention (PCI) has been increasingly employed to treat unprotected left main coronary artery (LMCA) stenosis, with variable success. This strategy has been applied to patients undergoing drug-eluting stent (DES) implantation for unprotected LMCA stenosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1557-2501
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
381-7
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17827507-Aged,
pubmed-meshheading:17827507-Aged, 80 and over,
pubmed-meshheading:17827507-Angioplasty, Balloon, Coronary,
pubmed-meshheading:17827507-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:17827507-Coronary Angiography,
pubmed-meshheading:17827507-Coronary Artery Disease,
pubmed-meshheading:17827507-Coronary Restenosis,
pubmed-meshheading:17827507-Drug Delivery Systems,
pubmed-meshheading:17827507-Female,
pubmed-meshheading:17827507-Follow-Up Studies,
pubmed-meshheading:17827507-Humans,
pubmed-meshheading:17827507-Immunosuppressive Agents,
pubmed-meshheading:17827507-Male,
pubmed-meshheading:17827507-Paclitaxel,
pubmed-meshheading:17827507-Predictive Value of Tests,
pubmed-meshheading:17827507-Prognosis,
pubmed-meshheading:17827507-Prospective Studies,
pubmed-meshheading:17827507-Risk Factors,
pubmed-meshheading:17827507-Sirolimus,
pubmed-meshheading:17827507-Stents,
pubmed-meshheading:17827507-Survival Rate,
pubmed-meshheading:17827507-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Outlook of drug-eluting stent implantation for unprotected left main disease: insights on long-term clinical predictors.
|
|
pubmed:affiliation |
School of Specialization of Cardiology, University of Florence, Florence, Florence, Italy. sabinevecchio@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
